Markers of androgen-independent progression of prostatic carcinoma

Prostate cancer (PCa) remains the most common cancer and the second leading cause of cancer mortality in men in the United States. The evolution from a localized to a metastatic phenotype coupled with the progression from an androgen-dependent (AD) to an androgen-independent (AI) state leads to a un...

Full description

Saved in:

Bibliographic Details
Published in:	Seminars in oncology Vol. 26; no. 4; p. 399
Main Authors:	Daliani, D, Papandreou, C N
Format:	Journal Article
Language:	English
Published:	United States 01-08-1999
Subjects:	Antigens, Neoplasm - metabolism Antigens, Surface Biomarkers, Tumor Carboxypeptidases - metabolism Cytokines - metabolism Disease Progression Genes, Tumor Suppressor Glutamate Carboxypeptidase II Growth Substances - metabolism Humans Male Neoplasms, Hormone-Dependent - genetics Neoplasms, Hormone-Dependent - metabolism Neoplasms, Hormone-Dependent - physiopathology Neurosecretory Systems - metabolism Oncogenes Prostate-Specific Antigen - metabolism Prostatic Neoplasms - genetics Prostatic Neoplasms - metabolism Prostatic Neoplasms - physiopathology Receptors, Androgen - metabolism
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Prostate cancer (PCa) remains the most common cancer and the second leading cause of cancer mortality in men in the United States. The evolution from a localized to a metastatic phenotype coupled with the progression from an androgen-dependent (AD) to an androgen-independent (AI) state leads to a universally fatal disease. Identifying the biologic characteristics associated with PCa progression is a major goal of current research efforts by different groups, in the hope to better predict the natural history of the disease in an individual patient and to design treatments based on the specific biologic behavior.
ISSN:	0093-7754